Grand Pharmaceutical Group - Stock

Grand Pharmaceutical Group Dividend 2024

Grand Pharmaceutical Group Dividend

0.14 HKD

Grand Pharmaceutical Group Dividend yield

2.97 %

Ticker

512.HK

ISIN

BMG210A71016

WKN

A0Q8LD

How much dividend does Grand Pharmaceutical Group 2024 pay?

According to the latest status from July 2024, Grand Pharmaceutical Group paid a total of 0.14 HKD per share in dividends within the last 12 months. With the current Grand Pharmaceutical Group price of 4.72 HKD, this corresponds to a dividend yield of 2.97 %. A dividend is paid times per year.

2.97 % Dividend Yield=
0.14 HKD Dividend
4.72 HKD Stock Price

Historical Grand Pharmaceutical Group Dividends

A dividend is paid times per year. Last year, the payout months were and July.

PaydateDividend
7/6/20240.26
7/9/20230.14
7/6/20220.11
7/8/20210.11
7/26/20200.1
7/12/20190.09
11/17/19960.02
7/18/19960.05
1

Grand Pharmaceutical Group Stock Dividend

In 2023, Grand Pharmaceutical Group paid a dividend amounting to 0.14 HKD. Dividend means that Grand Pharmaceutical Group distributes a portion of its profits to its owners.
  • 3 years

  • 5 years

  • 10 years

  • Max

Dividend
Dividend (Estimate)
Details

Dividend

Dividend Overview

The dividend per year chart for Grand Pharmaceutical Group provides a comprehensive view of the annual dividends distributed to shareholders. Analyze the trend to understand the consistency and growth in dividend payouts over the years.

Interpretation and Use

A consistent or increasing trend in dividends can indicate the company's profitability and financial health. Investors can use this data to identify Grand Pharmaceutical Group’s potential for long-term investment and income generation through dividends.

Investment Strategy

Incorporate the dividend data in evaluating Grand Pharmaceutical Group's overall performance. A thorough analysis, considering other financial aspects, will help in making informed investment decisions for optimal capital growth and income generation.

Grand Pharmaceutical Group Dividend History

DateGrand Pharmaceutical Group Dividend
2026e0.16 HKD
2025e0.16 HKD
2024e0.16 HKD
20230.14 HKD
20220.11 HKD
20210.11 HKD
20200.1 HKD
20190.09 HKD

Is the Grand Pharmaceutical Group Dividend Safe?

Grand Pharmaceutical Group has been increasing the dividend for 1 years.

Over the past 10 years, Grand Pharmaceutical Group has increased it by an annual 0 %.

Over a five-year period, the distribution increased by 0%.

Analysts expect a Dividend Increase of 5.886% for the current fiscal year.

Grand Pharmaceutical Group Stock Payout Ratio

In 2023, Grand Pharmaceutical Group had a payout ratio of 17.81%. The payout ratio indicates the percentage of the company's profits that Grand Pharmaceutical Group distributes as dividends.
  • 3 years

  • 5 years

  • 10 years

  • Max

Payout ratio
Details

Payout ratio

What is Yearly Payout Ratio?

The yearly payout ratio for Grand Pharmaceutical Group represents the proportion of earnings paid out as dividends to shareholders. It is an indicator of the company's financial health and stability, illustrating how much profit is being returned to investors versus being reinvested back into the company.

How to Interpret the Data

A lower payout ratio for Grand Pharmaceutical Group could mean that the company is reinvesting more into its growth, whereas a higher ratio indicates more earnings are being distributed as dividends. Investors seeking regular income might prefer companies with a higher payout ratio, while those looking for growth may opt for companies with a lower ratio.

Using the Data for Investments

Evaluate Grand Pharmaceutical Group's payout ratio in conjunction with other financial metrics and performance indicators. A sustainable payout ratio, coupled with strong financial health, can indicate a reliable dividend payout. However, a very high ratio might suggest the company is not sufficiently reinvesting in its future growth.

Grand Pharmaceutical Group Payout Ratio History

DateGrand Pharmaceutical Group Payout ratio
2026e17.82 %
2025e18.05 %
2024e17.6 %
202317.81 %
202218.74 %
202116.24 %
202018.45 %
201924.98 %
201817.81 %
201717.81 %
201617.81 %
201517.81 %
201417.81 %
201317.81 %
201217.81 %
201117.81 %
201017.81 %
200917.81 %
200817.81 %
200717.81 %
200617.81 %
200517.81 %
200417.81 %

Dividend Details

Understanding Grand Pharmaceutical Group's Dividend Distributions

Grand Pharmaceutical Group’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.

Year-to-Year Comparison

Examining Grand Pharmaceutical Group's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.

Impact on Investments

Grand Pharmaceutical Group's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.

Interpreting Dividend Fluctuations

Changes in Grand Pharmaceutical Group’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.

Grand Pharmaceutical Group Aktienanalyse

What does Grand Pharmaceutical Group do?

China Grand Pharmaceutical and Healthcare Holdings Ltd is an innovative company in the healthcare and pharmaceutical industry in China. The company was founded in 1997 and is headquartered in Wuhan, Hubei Province. China Grand Pharma specializes in developing, manufacturing, and distributing high-quality medications, medical devices, and services. The company has multiple subsidiaries involved in various areas of the healthcare and pharmaceutical industry. China Grand Pharma’s main business areas include the production and sale of synthetic drugs, traditional Chinese medicines, biopharmaceuticals, veterinary medicine, and medical devices and equipment. The company has a high level of technological expertise in synthetic drug development and has a team of experienced scientists and researchers. China Grand Pharma has continuously invested in research and development to develop innovative and effective medications that meet the needs of patients in China and worldwide. The traditional Chinese medicine segment is another important area of China Grand Pharma’s business. The company holds a leading position in the market and offers a wide range of products made from natural plant extracts and traditional Chinese medicines. Biopharmaceuticals, based on innovative technologies such as recombinant DNA technology or stem cell research, are another important focus of China Grand Pharma. The company is able to develop and manufacture high-quality biopharmaceuticals that can be used for the prevention and treatment of serious diseases. China Grand Pharma is also a major player in the veterinary medicine market and offers a wide range of products for the health of livestock and pets. The company has a high level of technological expertise and has an extensive portfolio of products for the diagnosis, prevention, and treatment of animal diseases. The company also offers a wide range of medical devices and equipment for healthcare in hospitals and clinics. China Grand Pharma provides a variety of products, from diagnostic instruments to surgical tools. Overall, China Grand Pharmaceutical and Healthcare Holdings Ltd is one of the leading companies in the healthcare and pharmaceutical industry in China. The company has a comprehensive range of products and is able to provide high-quality products and services for a variety of applications and needs. China Grand Pharma is highly committed to researching and developing medications and technologies that can improve healthcare in China and enhance the lives of patients worldwide. The company has a strong presence in the Chinese market and has a well-established distribution infrastructure that allows it to distribute its products and services in China and beyond. Grand Pharmaceutical Group is one of the most popular companies on Eulerpool.com.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Frequently Asked Questions about Grand Pharmaceutical Group stock

How much dividend does Grand Pharmaceutical Group pay?

Over the past 12 months, Grand Pharmaceutical Group paid a dividend of 0.14 HKD . This corresponds to a dividend yield of about 2.97 %. For the coming 12 months, Grand Pharmaceutical Group is expected to pay a dividend of 0.16 HKD.

What is the dividend yield of Grand Pharmaceutical Group?

The current dividend yield of Grand Pharmaceutical Group is 2.97 %.

When does Grand Pharmaceutical Group pay dividends?

Grand Pharmaceutical Group pays a quarterly dividend. This is distributed in the months of July, July, July, July.

How secure is the dividend of Grand Pharmaceutical Group?

Grand Pharmaceutical Group paid dividends every year for the past 8 years.

What is the dividend of Grand Pharmaceutical Group?

For the upcoming 12 months, dividends amounting to 0.16 HKD are expected. This corresponds to a dividend yield of 3.32 %.

In which sector is Grand Pharmaceutical Group located?

Grand Pharmaceutical Group is assigned to the 'Health' sector.

Wann musste ich die Aktien von Grand Pharmaceutical Group kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Grand Pharmaceutical Group from 6/27/2024 amounting to 0.26 HKD, you needed to have the stock in your portfolio before the ex-date on 6/6/2024.

When did Grand Pharmaceutical Group pay the last dividend?

The last dividend was paid out on 6/27/2024.

What was the dividend of Grand Pharmaceutical Group in the year 2023?

In the year 2023, Grand Pharmaceutical Group distributed 0.11 HKD as dividends.

In which currency does Grand Pharmaceutical Group pay out the dividend?

The dividends of Grand Pharmaceutical Group are distributed in HKD.

Andere Kennzahlen von Grand Pharmaceutical Group

Our stock analysis for Grand Pharmaceutical Group Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Grand Pharmaceutical Group Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.